246 related articles for article (PubMed ID: 7592576)
1. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.
Pike CJ; Overman MJ; Cotman CW
J Biol Chem; 1995 Oct; 270(41):23895-8. PubMed ID: 7592576
[TBL] [Abstract][Full Text] [Related]
2. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.
Pike CJ; Walencewicz-Wasserman AJ; Kosmoski J; Cribbs DH; Glabe CG; Cotman CW
J Neurochem; 1995 Jan; 64(1):253-65. PubMed ID: 7798921
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42.
Tekirian TL; Yang AY; Glabe C; Geddes JW
J Neurochem; 1999 Oct; 73(4):1584-9. PubMed ID: 10501204
[TBL] [Abstract][Full Text] [Related]
5. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
[TBL] [Abstract][Full Text] [Related]
6. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
7. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.
Petkova AT; Leapman RD; Guo Z; Yau WM; Mattson MP; Tycko R
Science; 2005 Jan; 307(5707):262-5. PubMed ID: 15653506
[TBL] [Abstract][Full Text] [Related]
8. Aggregation of amyloid beta-protein and its neurotoxicity: enhancement by aluminum and other metals.
Kuroda Y; Kawahara M
Tohoku J Exp Med; 1994 Nov; 174(3):263-8. PubMed ID: 7761991
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB
Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
11. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid.
Chimon S; Shaibat MA; Jones CR; Calero DC; Aizezi B; Ishii Y
Nat Struct Mol Biol; 2007 Dec; 14(12):1157-64. PubMed ID: 18059284
[TBL] [Abstract][Full Text] [Related]
12. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
[TBL] [Abstract][Full Text] [Related]
13. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
14. Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity.
Roychaudhuri R; Zheng X; Lomakin A; Maiti P; Condron MM; Benedek GB; Bitan G; Bowers MT; Teplow DB
ACS Chem Neurosci; 2015 Dec; 6(12):1941-55. PubMed ID: 26421877
[TBL] [Abstract][Full Text] [Related]
15. Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids.
Galante D; Corsaro A; Florio T; Vella S; Pagano A; Sbrana F; Vassalli M; Perico A; D'Arrigo C
Int J Biochem Cell Biol; 2012 Nov; 44(11):2085-93. PubMed ID: 22903022
[TBL] [Abstract][Full Text] [Related]
16. Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.
Russo C; Violani E; Salis S; Venezia V; Dolcini V; Damonte G; Benatti U; D'Arrigo C; Patrone E; Carlo P; Schettini G
J Neurochem; 2002 Sep; 82(6):1480-9. PubMed ID: 12354296
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide.
Paul A; Nadimpally KC; Mondal T; Thalluri K; Mandal B
Chem Commun (Camb); 2015 Feb; 51(12):2245-8. PubMed ID: 25514992
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40: a kinetic model.
Taylor BM; Sarver RW; Fici G; Poorman RA; Lutzke BS; Molinari A; Kawabe T; Kappenman K; Buhl AE; Epps DE
J Protein Chem; 2003 Jan; 22(1):31-40. PubMed ID: 12739896
[TBL] [Abstract][Full Text] [Related]
19. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
20. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.
Huang TH; Yang DS; Fraser PE; Chakrabartty A
J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
